Inventor · disambiguated record
Lars Joenson
Also filed as: JOENSON LARS
2 granted patents·18 pending applications·0 citations·filing 2017–2024
29Inventor score
Files withHOFFMANN LA ROCHE11ROCHE INNOVATION CT COPENHAGEN AS7BOEHRINGER INGELHEIM INT1WORM JESPER1
Top patents by PatentIndex Score
20 records- 0175US2025136984A1Oligonucleotide agonists targeting progranulinHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0267US2023287412A1Oligonucleotide Agonists Targeting ProgranulinHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0365US12203071B2Oligonucleotide agonists targeting progranulinHOFFMANN LA ROCHE·Filed 2021·Granted Jan 21, 2025·0 cites·15 claims
- 0465US2024327837A1Oligonucleotides targeting rna binding protein sitesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0562US2023002762A1Oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2022·Application pending·0 cites
- 0660US12084657B2Oligonucleotides targeting RNA binding protein sitesHOFFMANN LA ROCHE·Filed 2021·Granted Sep 10, 2024·0 cites·31 claims
- 0760US2025290068A2Improved oligonucleotides targeting rna binding protein sitesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0860US2025361507A2Antisense oligonucleotides for targeting progranulinWORM JESPER·Filed 2024·Application pending·0 cites
- 0956US2024327845A1Antisense oligonucleotides targeting unc13aHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1055US2024318180A1Antisense oligonucleotides targeting actl6bHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1155US2024336919A1Rna editingHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1254US2021269851A1Massively parallel discovery methods for oligonucleotide therapeuticsROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 1354US2022002796A1Quality control of lna oligonucleotide therapeutics using massively parallel sequencingROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 1454US2021071247A1Massively parallel discovery methods for oligonucleotide therapeuticsROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 1553US2020339982A1Oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 1652US2022403388A1Oligonucleotide Progranulin AgonistsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1751US2023122753A1Oligonucleotides for modulating cd73 exon 7 splicingHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1851US2023193269A1Oligonucleotides for splice modulation of card9BOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1943US2022160870A1Neoantigen engineering using splice modulating compoundsROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 2036US2019284621A1Therapeutic oligonucleotides capture and detectionROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Joenson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →